NTT Research, an arm of NTT, has announced that it has reportedly opened a new office in Munich, Germany, rendering support to a joint research agreement it had entered into, with the TUM (Technical University of Munich), in November 2019. If reports are to be believed, this joint research agreement relates NTT Research's MEI (Medical and Health Informatics) Lab with the Neuroelectronics Group in Munich School of BioEngineering in TUM.
The Munich office will be led by Dr. Tetsuhiko Teshima, who apparently is an expert in nanomaterials and also boasts of the dual titles of Visiting Researcher in Neuroelectronics Group, TUM, and Research Scientist in the MEI Lab.
Hitonobu Tomoike, M.D., Ph.D., and Lab Director, MEI, has been claimed to state that the establishment is thrilled to officially set up its new branch office in Munich, in support of the endeavor with TUM. MEI believes that this will be well-suited for Dr. Teshima, as he continues to pursue the Lab’s joint goals with TUM so as to develop flexible, high biocompatibility electrodes, Tomoike adds.
For the uninitiated, MEI Lab's two basic fields of research include the nanosensor technology and bio digital twin initiative, and the collaboration with the Neuroelectronics Group at TUM involves the former – more specifically, 3D transformable and implantable electrodes. The scope of this multi-year research project is inclusive of initially screening and optimizing the functional materials, then assembling 3D structures, and later, evaluating their biocompatibility. The MEI Lab office in Munich another sign of the commitment that NTT Research had to this venture, in tandem with its goal of expanding its presence beyond Silicon Valley.
Sources familiar with the knowledge of the matter claim that Dr. Teshima, at TUM, is on the scientific staff, Neuroelectronics Group, led by Dr. Bernard Wolfrum, working at TUM, as the Professor of Neuroelectronics, in the Department of Electrical and Computer Engineering and the MSB (Munich School of BioEngineering).